105 related articles for article (PubMed ID: 27125346)
1. Survival Prognostication in Patients with Skeletal Metastases from Nasopharyngeal Carcinoma: An Evaluation of the Scandinavian Sarcoma Group, Katagiri and Bauer Scoring Systems.
Tan JJ; Zaw AS; Malhotra R; Wai KL; Tan JY; Kumar N
Ann Acad Med Singap; 2016 Feb; 45(2):51-60. PubMed ID: 27125346
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of scoring systems and prognostic factors in patients with spinal metastases from nasopharyngeal carcinoma.
Kumar N; Tan JJ; Zaw AS; Lim JL; Wai KL; Malhotra R; Loh TK; Liu GK; Thambiah J
Spine J; 2014 Dec; 14(12):2946-53. PubMed ID: 24912121
[TBL] [Abstract][Full Text] [Related]
3. Predicting the survival of patients with bone metastases treated with radiation therapy: a validation study of the Katagiri scoring system.
Kubota H; Soejima T; Sulaiman NS; Sekii S; Matsumoto Y; Ota Y; Tsujino K; Fujita I; Fujimoto T; Morishita M; Ikegaki J; Matsumoto K; Sasaki R
Radiat Oncol; 2019 Jan; 14(1):13. PubMed ID: 30658673
[TBL] [Abstract][Full Text] [Related]
4. Risk subset of the survival for nasopharyngeal carcinoma patients with bone metastases: who will benefit from combined treatment?
Cao X; Han Y; He L; Xiang J; Wen Z
Oral Oncol; 2011 Aug; 47(8):747-52. PubMed ID: 21665523
[TBL] [Abstract][Full Text] [Related]
5. The Glasgow Prognostic Score predicts poor survival in cisplatin-based treated patients with metastatic nasopharyngeal carcinoma.
Chen C; Sun P; Dai QS; Weng HW; Li HP; Ye S
PLoS One; 2014; 9(11):e112581. PubMed ID: 25393117
[TBL] [Abstract][Full Text] [Related]
6. Oligometastases in AJCC stage IVc nasopharyngeal carcinoma: A subset with better overall survival.
Tian YH; Zou WH; Xiao WW; Zeng L; Yuan X; Bai L; Lu T; Tian Y; Han F
Head Neck; 2016 Aug; 38(8):1152-7. PubMed ID: 27220062
[TBL] [Abstract][Full Text] [Related]
7. Prognostic Evaluation of Nasopharyngeal Carcinoma with Bone-Only Metastasis after Therapy.
Lu T; Guo Q; Cui X; Chen Z; Lin S; Xu L; Lin J; Zong J; Pan J
Yonsei Med J; 2016 Jul; 57(4):840-5. PubMed ID: 27189275
[TBL] [Abstract][Full Text] [Related]
8. [Evaluation of the prognostic significance of refinement and stratification of distant metastasis status in 1016 cases of nasopharyngeal carcinoma].
Pan CC; Lu J; Chen P; Li X; Jin YD; Zhao M; Xia YF; Wu PH
Zhonghua Zhong Liu Za Zhi; 2013 Aug; 35(8):595-9. PubMed ID: 24314217
[TBL] [Abstract][Full Text] [Related]
9. Survival analysis of 254 patients after manifestation of spinal metastases: evaluation of seven preoperative scoring systems.
Wibmer C; Leithner A; Hofmann G; Clar H; Kapitan M; Berghold A; Windhager R
Spine (Phila Pa 1976); 2011 Nov; 36(23):1977-86. PubMed ID: 21304424
[TBL] [Abstract][Full Text] [Related]
10. Development and external validation of nomograms to predict the risk of skeletal metastasis at the time of diagnosis and skeletal metastasis-free survival in nasopharyngeal carcinoma.
Yang L; Xia L; Wang Y; He S; Chen H; Liang S; Peng P; Hong S; Chen Y
BMC Cancer; 2017 Sep; 17(1):628. PubMed ID: 28874126
[TBL] [Abstract][Full Text] [Related]
11. Prospective validation of the prognostic value of elevated serum vascular endothelial growth factor in patients with nasopharyngeal carcinoma: more distant metastases and shorter overall survival after treatment.
Lv X; Xiang YQ; Cao SM; Qian CN; Li NW; Guo L; Mai HQ; Chen QY; Huang PY; Luo D; Cao KJ; Hong MH; Guo X
Head Neck; 2011 Jun; 33(6):780-5. PubMed ID: 20967862
[TBL] [Abstract][Full Text] [Related]
12. The Scandinavian Sarcoma Group Skeletal Metastasis Register. Survival after surgery for bone metastases in the pelvis and extremities.
Hansen BH; Keller J; Laitinen M; Berg P; Skjeldal S; Trovik C; Nilsson J; Walloe A; Kalén A; Wedin R
Acta Orthop Scand Suppl; 2004 Apr; 75(311):11-5. PubMed ID: 15188660
[TBL] [Abstract][Full Text] [Related]
13. Long term outcomes and prognostic factors of n0 stage nasopharyngeal carcinoma: a single institutional experience with 610 patients.
Sun JD; Chen CZ; Chen JZ; Li DS; Chen ZJ; Zhou MZ; Li DR
Asian Pac J Cancer Prev; 2012; 13(5):2101-7. PubMed ID: 22901177
[TBL] [Abstract][Full Text] [Related]
14. Relapse status as a prognostic factor in patients receiving salvage surgery for recurrent or residual nasopharyngeal cancer after definitive treatment.
Chee J; Ting Y; Ong YK; Chao SS; Loh KS; Lim CM
Head Neck; 2016 Sep; 38(9):1393-400. PubMed ID: 27043448
[TBL] [Abstract][Full Text] [Related]
15. Prognostic factors of nasopharyngeal carcinoma patients in a tertiary referral hospital: a retrospective cohort study.
Siti-Azrin AH; Norsa'adah B; Naing NN
BMC Res Notes; 2017 Dec; 10(1):705. PubMed ID: 29212521
[TBL] [Abstract][Full Text] [Related]
16. Prediction of post-radiotherapy survival for bone metastases: a comparison of the 3-variable number of risk factors model with the new Katagiri scoring system.
Sakurai T; Takamatsu S; Shimoyachi N; Shibata S; Makino M; Ohashi S; Taima Y; Minamikawa R; Kumano T; Gabata T
J Radiat Res; 2022 Mar; 63(2):303-311. PubMed ID: 34977925
[TBL] [Abstract][Full Text] [Related]
17. Serum lactic dehydrogenase strongly predicts survival in metastatic nasopharyngeal carcinoma treated with palliative chemotherapy.
Jin Y; Ye X; Shao L; Lin BC; He CX; Zhang BB; Zhang YP
Eur J Cancer; 2013 May; 49(7):1619-26. PubMed ID: 23266049
[TBL] [Abstract][Full Text] [Related]
18. To build a prognostic score model containing indispensible tumour markers for metastatic nasopharyngeal carcinoma in an epidemic area.
Jin Y; Cai XY; Cai YC; Cao Y; Xia Q; Tan YT; Jiang WQ; Shi YX
Eur J Cancer; 2012 Apr; 48(6):882-8. PubMed ID: 22030451
[TBL] [Abstract][Full Text] [Related]
19. Predicting survival for metastatic spine disease: a comparison of nine scoring systems.
Ahmed AK; Goodwin CR; Heravi A; Kim R; Abu-Bonsrah N; Sankey E; Kerekes D; De la Garza Ramos R; Schwab J; Sciubba DM
Spine J; 2018 Oct; 18(10):1804-1814. PubMed ID: 29567516
[TBL] [Abstract][Full Text] [Related]
20. Clinical utility of 18F-FDG PET parameters in patients with advanced nasopharyngeal carcinoma: predictive role for different survival endpoints and impact on prognostic stratification.
Chan SC; Chang JT; Lin CY; Ng SH; Wang HM; Liao CT; Chang CJ; Lin SY; Yen TC
Nucl Med Commun; 2011 Nov; 32(11):989-96. PubMed ID: 21862944
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
